Crux Biomedical Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $39M
Latest Deal Amount
  • Investors
  • 1

Crux Biomedical General Information

Description

Developer of a preventive device for pulmonary embolisms. The company provide Crux VCF System, that stops the blood clots from reaching the lungs. It is useful for patients at risk of pulmonary embolism who can't tolerate blood thinners, method of preventing clots.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Acquirer
Primary Office
  • 1455 Adams Drive
  • Suite 1170
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crux Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 12-Dec-2012 $39M 000.00 0000 Completed Generating Revenue
6. Later Stage VC (Series D) 07-Jun-2011 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 01-Mar-2011 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 22-Jan-2009 000 000.00 Completed Generating Revenue
3. Later Stage VC 08-Dec-2008 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 02-Oct-2007 $2.5M $6.35M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Sep-2006 $3.85M $3.85M Completed Product Development
To view Crux Biomedical’s complete valuation and funding history, request access »

Crux Biomedical Executive Team (4)

Name Title Board Seat Contact Info
Mel Schatz President & Chief Executive Officer
Christopher Schaffer Chief Financial Officer
Murli Srinivasan Director, Operations
Eric Johnson Vice President, Research & Development
To view Crux Biomedical’s complete executive team members history, request access »

Crux Biomedical Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alloy Ventures Venture Capital Minority 000 0000 000000 0
Emergent Medical Partners Venture Capital Minority 000 0000 000000 0
Hercules Capital Lender/Debt Provider Minority 000 0000 000000 0
Kevin D'Silva Angel (individual) Minority 000 0000 000000 0
Three Arch Partners Venture Capital Minority 000 0000 000000 0
To view Crux Biomedical’s complete investors history, request access »